Investigation of a Link Between Heart Rate Variability and Frailty in Geriatric Patients

September 16, 2019 updated by: RWTH Aachen University

Investigation of a Link Between Heart Rate Variability and Frailty in Geriatric Patients Before and After Rehabilitation With Simultaneous Evaluation of a New Camera-based Technology for Measurement of Vital Signs

The aim of this study is the evaluation of differences in heart rate variability (both time- and frequency-domain) [a]: between frail and non-frail patients and [b] at the beginning and end of a geriatric therapy which included rehabilitation components. Moreover, the suitability of new camera-based technology with regard to measurement of vital signs (heart rate, heart rate variability, respiratory rate) will be evaluated.

Study Overview

Detailed Description

Frailty is an important geriatric syndrome, which indicates a reduced maximum resilience of patients and their organ system against external stressors. According to Fried's classification, frailty comprises of unintentional weight loss, exhaustion, muscle weakness, slowness while walking and low levels of activity. In geriatric patients, frailty is associated with a higher mortality and morbidity. Moreover, frailty patients are more often dependent on assistance after hospitalisation than non-frailty patients.

During geriatric therapy, geriatric patients are treated with multimodal rehabilitation comprising of activating nursing, physiotherapy, occupational therapy, psychiatric and speech therapy in order to increase mobility and patients' ability to help themselves. Success of rehabilitation measures is measured using the geriatric assessment (e.g. Barthel Index, Timed up and go test, Mini-Mental State Examination, Geriatric Depression Scale, measurement of hand power) at the beginning and end of the therapy. This geriatric therapy including the named geriatric assessment is not study-specific and is not prescribed by a study protocol, but is a routine treatment for frail patients.

Apart from these routinely used tests, recent literature indicated that heart rate variability, which can be easily measured with an ECG, could be an indicator for frailty. Beyond the medical problem whether heart rate variability can be used as a surrogate parameter for frailty, this study also has a technical aspect. In biomedical engineering, non-contact monitoring of vital signs has been an important and promising development in the last decade. Therefore, this study will also investigate if camera-based technologies such as photoplethysmography imaging (PPGI) and infrared thermography (IRT) can be used in a clinical environment for non-contact measurement of vital signs (heart rate, heart rate variability, respiratory rate) in geriatric patients. In this study, monitoring (with conventional and contactless technologies) should not trigger any observable/examining effect, but is merely a means to the end of observing the already existing HRV (and other vital parameters).

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Rhine-Westphalia
      • Aachen, North Rhine-Westphalia, Germany, 52074
        • Department of Geriatrics, University Hospital RWTH Aachen Aachen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

10 patients above 70 years with frailty form the geriatric medicine ward in the Franziskushospital Aachen and 10 healthy volunteers with age above 70 years without frailty

Description

Inclusion Criteria:

  • Group 1: aged above 70 if they have typical geriatric multimorbidity, otherwise aged above 80, patient on the geriatric ward in the hospital "Franziskhospital Aachen"
  • Group 2 (Healthy volunteers): aged above 70, healthy and in good physical condition
  • Written informed consent by patient / volunteer

Exclusion Criteria:

  • Inability to consent
  • Pace maker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1
10 patients aged above 70 years with typical geriatric multimorbidity or aged above 80 years otherwise, patient in the hospital Franziskushospital Aachen on the ward of geriatric medicine
Measurement of reference data: heart rate, heart rate variability and respiratory rate
Camera-based technology for the determination of heart rate variability (PPGI) and contactless measurement of breathing rate (IRT)
Group 2
10 healthy elderly people above 70 years, healthy
Measurement of reference data: heart rate, heart rate variability and respiratory rate
Camera-based technology for the determination of heart rate variability (PPGI) and contactless measurement of breathing rate (IRT)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Link between heart rate variability and frailty
Time Frame: approx. 14 days (duration of geriatric complex therapy)

heart rate variability is measured by ECG; frailty is evaluated by geriatric assessment (questionnaires)

both investigations are not related to the study but geriatric complex therapy

approx. 14 days (duration of geriatric complex therapy)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation and precision of camera-based heart rate measurement with reference data from standard patient monitor
Time Frame: approx. 14 days (duration of geriatric complex therapy)

the following devices / methods are used to record the heart rate:

  • camera-based measurement: photoplethysmography imaging (PPGI);
  • reference data: ECG
approx. 14 days (duration of geriatric complex therapy)
Correlation and precision of camera-based heart rate variability with reference data from standard patient monitor
Time Frame: approx. 14 days (duration of geriatric complex therapy)

the following devices are used to record the heart rate variability:

  • camera-based measurement: photoplethysmography imaging (PPGI);
  • reference data: Pulsoximeter (fingerclip)
approx. 14 days (duration of geriatric complex therapy)
Correlation and precision of camera-based respiratory rate with reference data from standard patient monitor
Time Frame: approx. 14 days (duration of geriatric complex therapy)

the following devices / methods are used to record the respiratory rate:

  • camera-based measurement: infrared thermography (IRT);
  • reference data: ECG
approx. 14 days (duration of geriatric complex therapy)
Development of Frailty / geriatric assessment at the beginning and end of the geriatric early-rehabilitation complex-therapy
Time Frame: approx. 14 days (duration of geriatric complex therapy)
Frailty is evaluated by geriatric assessment (questionnaires)
approx. 14 days (duration of geriatric complex therapy)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cornelius Bollheimer, Univ.-Prof. Dr. med., Department of Geriatrics, University Hospital RWTH Aachen Aachen, NRW, Germany, 52074 Contacts:

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2018

Primary Completion (Actual)

April 12, 2019

Study Completion (Actual)

April 12, 2019

Study Registration Dates

First Submitted

May 24, 2018

First Submitted That Met QC Criteria

July 2, 2018

First Posted (Actual)

July 13, 2018

Study Record Updates

Last Update Posted (Actual)

September 17, 2019

Last Update Submitted That Met QC Criteria

September 16, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 18-059

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fragility

Clinical Trials on Standard patient monitor

Subscribe